Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 11—November 2024
Dispatch

Fatal Oropouche Virus Infections in Nonendemic Region, Brazil, 2024

Antonio Carlos Bandeira, Felicidade Mota Pereira, Arabela Leal, Sara P.O. Santos, Ana Claudia Barbosa, Marcia Sao Pedro Leal Souza, Daniele Ribeiro de Souza, Natalia Guimaraes, Vagner Fonseca, Marta Giovanetti, Luiz Carlos Junior Alcantara, André Alvarez A. Lessa, Ramon Costa Saavedra, Luiz Marcelo R. Tomé, Felipe Campos M. Iani, Rivia Mary Barros, Sandra Maria O. Purificação, Jaciara Prado de Jesus, Ricardo Rosário Fonseca, and Marcio Luis Valença AraújoComments to Author 
Author affiliations: Laboratório Central de Saúde Pública da Bahia, Salvador, Brazil (A.C. Bandeira, F. Mota Pereira, A. Leal, S.P.O. Santos); Diretoria de Vigilância Epidemiológica do Estado da Bahia, Salvador (A.C. Barbosa, M.S.P.L. Souza, D.R. de Souza, A.A.A. Lessa, R.C. Saavedra, S.M. de Oliveira da Purificação, J.P. de Jesus, M.L.V. Araújo); Fundação Ezequiel Dias, Belo Horizonte, Brazil (N. Guimaraes, F.C.M. Iani); University of the State of Bahia, Salvador (V. Fonseca); Universita Campus Bio-Medico di Roma, Rome, Italy (M. Giovanetti); Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil (M. Giovanetti); Instituto Rene Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil (L.C.J. Alcantara, L.M.R. Tomé); Superintendência de Vigilância em Saúde, Salvador (R.M. Barros); Santa Casa de Misericórdia de Valença Hospital, Valença, Brazil (R.R. Fonseca); Instituto Federal de Educação, Salvador (M.L.V. Araújo)

Main Article

Table 1

Laboratory results for patient 1 after admission in a case of fatal Oropouche virus infection in nonendemic region, Brazil, 2024*

Variable Time after admission
6 hours 13 hours
Hematocrit, % 50.3 20.9
Hemoglobin, % 16.7 7.0
Mean corpuscular volume, fL(reference <80 fL) 80 88
Mean corpuscular hemoglobin, pg (reference 27–31 pg) 27 29
Leukocytes, cells/mm3 44,700 24,500
Neutrophils, % 71 80
Band forms, % 8 10
Metamyelocytes, % 1 1
Lymphocytes, % 16 6
Platelets, cells/mm3 125,000 43,000
Bleeding time, min ND 1
Clotting time, min ND >30
Clot retraction ND Complete
AST, U/L ND 970
ALT, U/L 7 404
GGT, U/L 559 144
TB/DB, mg/dL 2.78/1.52 ND
Creatinine, mg/dL 4.1 2.3

*AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; ND, not done; TB/DB, total/direct bilirubin.

Main Article

Page created: September 10, 2024
Page updated: September 13, 2024
Page reviewed: September 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external